156 related articles for article (PubMed ID: 36822475)
1. An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement.
Davis E; Archer A; Flynn J; Nhaissi M; Rapoport C; Suri B; Wells D; Papadopoulos E; Politikos I; Fingrut WB; Scaradavou A; Barker JN
Transplant Cell Ther; 2023 May; 29(5):312.e1-312.e5. PubMed ID: 36822475
[TBL] [Abstract][Full Text] [Related]
2. Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.
Davis E; Devlin S; Cooper C; Nhaissi M; Paulson J; Wells D; Scaradavou A; Giralt S; Papadopoulos E; Kernan NA; Byam C; Barker JN
Biol Blood Marrow Transplant; 2018 May; 24(5):1057-1062. PubMed ID: 29287807
[TBL] [Abstract][Full Text] [Related]
3. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W
Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.
Acevedo MJ; Wilder JS; Adams S; Davis J; Kelly C; Hilligoss D; Carroll E; Blacklock-Schuver B; Cole K; Kang EM; Hsu AP; Kanakry CG; Dimitrova D; Kanakry JA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1666-1673. PubMed ID: 30986499
[TBL] [Abstract][Full Text] [Related]
5. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
6. Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia.
Fingrut WB; Gyurkocza B; Flynn J; Davis E; Devlin S; Scaradavou A; Chinapen S; Quach S; Cho C; Giralt SA; Jakubowski AA; Lin RJ; Papadopoulos EB; Perales MA; Ponce D; Shaffer BC; Tamari R; Young JW; Politikos I; Barker JN
Blood Adv; 2023 Aug; 7(15):3824-3833. PubMed ID: 36240477
[TBL] [Abstract][Full Text] [Related]
7. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
[TBL] [Abstract][Full Text] [Related]
8. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.
Rubio MT; Savani BN; Labopin M; Polge E; Niederwieser D; Ganser A; Schwerdtfeger R; Ehninger G; Finke J; Renate A; Craddock C; Kröger N; Hallek M; Jindra P; Mohty M; Nagler A
J Hematol Oncol; 2016 Aug; 9(1):65. PubMed ID: 27488518
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.
Barker JN; Boughan K; Dahi PB; Devlin SM; Maloy MA; Naputo K; Mazis CM; Davis E; Nhaissi M; Wells D; Cooper C; Ponce DM; Kernan N; Scaradavou A; Giralt SA; Papadopoulos EB; Politikos I
Blood Adv; 2019 Apr; 3(7):939-944. PubMed ID: 30917950
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.
Smith AR; Baker KS; Defor TE; Verneris MR; Wagner JE; Macmillan ML
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1086-93. PubMed ID: 19660721
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
[No Abstract] [Full Text] [Related]
13. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.
Weisdorf D; Eapen M; Ruggeri A; Zhang MJ; Zhong X; Brunstein C; Ustun C; Rocha V; Gluckman E
Biol Blood Marrow Transplant; 2014 Jun; 20(6):816-22. PubMed ID: 24582782
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation from unrelated donors in acute leukaemia.
Lozano Cerrada S; Altaf SY; Olavarria E
Curr Opin Oncol; 2018 Nov; 30(6):418-424. PubMed ID: 30222641
[TBL] [Abstract][Full Text] [Related]
15. Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely.
Olson JA; Gibbens Y; Tram K; Kempenich J; Novakovich J; Buck K; Dehn J
HLA; 2017 Feb; 89(2):77-81. PubMed ID: 28102042
[TBL] [Abstract][Full Text] [Related]
16. Racial/ ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation.
Fingrut WB; Davis E; Archer A; Brown S; Devlin SM; Nhaissi M; Rapoport C; Chinapen S; Kelly A; Wells DS; Scaradavou A; Gyurkocza B; Papadopoulos EB; Politikos I; Shaffer BC; Barker J
Blood Adv; 2024 Mar; ():. PubMed ID: 38429097
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.
Kumar P; Defor TE; Brunstein C; Barker JN; Wagner JE; Weisdorf DJ; Burns LJ
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1394-400. PubMed ID: 19041062
[TBL] [Abstract][Full Text] [Related]
18. Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor.
Fingerson S; Maiers M; Bolon YT; Devine SM; Spellman SR
Blood Adv; 2024 Feb; 8(3):758-765. PubMed ID: 38127270
[TBL] [Abstract][Full Text] [Related]
19. Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma.
Avivi I; Canals C; Vernant JP; Wulf G; Nagler A; Hermine O; Petersen E; Yakoub-Agha I; Craddock C; Schattenberg A; Niederwieser D; Thomson K; Blaise D; Attal M; Pfreundschuh M; Passweg J; Russell N; Dreger P; Sureda A;
Bone Marrow Transplant; 2014 May; 49(5):671-8. PubMed ID: 24510071
[TBL] [Abstract][Full Text] [Related]
20. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
